Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PC 18:1_19:2)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004451 AN007455 Lipidomics profiling of NMNAT2–SARM1 pathway modulation in mouse cortical neurodegeneration Brain cortex Mouse Neurodegenerative disease Indiana University Bloomington LC-MS
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003694 AN006060 FOLFIRINOX effects on lipidomics in pancreatic cancer cells Pancreas Human Cancer Pennsylvania State University LC-MS
ST003664 AN006020 Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function. T-cells Mouse Cancer University of Chicago LC-MS
ST003637 AN005974 lomitapide effects on lipidomics Pancreas Human Cancer Pennsylvania State University LC-MS
ST003328 AN005452 Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular lipidomics Stem cells Human Multiple sclerosis University of Colorado Denver LC-MS
ST003328 AN005453 Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular lipidomics Stem cells Human Multiple sclerosis University of Colorado Denver LC-MS
ST003222 AN005283 A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 Heart Mouse Ischemia University of Mississippi Medical Center LC-MS
ST003130 AN005133 Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Maternal blood Blood Mouse University of Copenhagen LC-MS
  logo